Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels
SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data.
Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO
The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.
Toddler dies after allegedly being given 10 times too much potassium due to decimal error
A lawsuit contends that De’Markus Page, 2 years old, died because no one at University of Florida Health’s Shands Teaching Hospital spotted the errors, which should have been labeled as a “red flag” by EHR systems.
Drinking coffee may reduce risk of recurrent AFib
Physicians often tell AFib patients they should limit coffee consumption to protect their hearts. This new analysis, however, suggests that may not be necessary.
AI-enabled coronary plaque quantification outperforms traditional risk scores
Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.

Even mild myocardial injuries are a bad sign for COVID-19 patients

Researchers have found a link between myocardial injury and a higher risk of death among patients hospitalized in the United States for COVID-19.

First drug found to improve COVID-19 survival

A commonly known steroid drug has been found to greatly improve survival for COVID-19 patients. In fact, among severe patients, the steroid, Dexamethasone, reduced the number of deaths by one-third in a study conducted by the University of Oxford.

FDA says hydroxychloroquine unlikely to be effective in treating COVID-19

The FDA has revoked its emergency use authorization for hydroxychloroquine as a treatment for COVID-19 hospital patients, determining that the controversial drug was “unlikely to be effective in treating COVID-19.”

Update: FDA names 5 companies recalling extended-release metformin

The FDA has provided new information about the metformin recall first announced in May.

Cardiologist makes history, performs first cardioneural ablation in US

A cardiologist at the University of Chicago Medicine has performed the first cardioneural ablation in U.S. history, using it to “rewire” the heart of a patient suffering from vasovagal syncope.

Spectacular science: 3D model offers breathtaking look at what happens during a heart attack

So what, exactly, occurs inside the human heart during a myocardial infarction?

Gene-editing specialists raise $63M to combat coronary heart disease

Verve Therapeutics, a healthcare company focused on improving cardiovascular outcomes through gene-editing technology, has raised $63 million in Series A2 financing.

New payment model could save rural hospitals from a post-COVID collapse

The COVID-19 pandemic hit rural hospitals especially hard—and that’s bad news for patients in areas already associated with poor cardiovascular outcomes.

Clinical

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels

Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO

Toddler dies after allegedly being given 10 times too much potassium due to decimal error

Drinking coffee may reduce risk of recurrent AFib

AI-enabled coronary plaque quantification outperforms traditional risk scores